Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

BACKGROUND: The identification of novel targets is of paramount importance to develop more effective drugs and improve the treatment of non-small cell lung cancer (NSCLC), the leading cause of cancer-related deaths worldwide. Since cells alter their metabolic rewiring during tumorigenesis and along...

Descripción completa

Detalles Bibliográficos
Autores principales: Parma, Beatrice, Ramesh, Vignesh, Gollavilli, Paradesi Naidu, Siddiqui, Aarif, Pinna, Luisa, Schwab, Annemarie, Marschall, Sabine, Zhang, Shuman, Pilarsky, Christian, Napoli, Francesca, Volante, Marco, Urbanczyk, Sophia, Mielenz, Dirk, Schrøder, Henrik Daa, Stemmler, Marc, Wurdak, Heiko, Ceppi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348813/
https://www.ncbi.nlm.nih.gov/pubmed/34364401
http://dx.doi.org/10.1186/s13046-021-02049-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348813/
https://www.ncbi.nlm.nih.gov/pubmed/34364401
http://dx.doi.org/10.1186/s13046-021-02049-8

Ejemplares similares